Prognostic factors in differentiated thyroid cancer - A 20-year surgical outcome study

Langenbeck's Archives of Surgery

Volumn 397, Issue 5, 2012, Pages 809-815

  Konturek, Aleksander ^a   Barczyński, Marcin ^a   Nowak, Wojciech ^a   Richter, Piotr ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Relative risk of death; Total thyroidectomy; Well differentiated thyroid cancer

Indexed keywords

CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; DIFFERENTIATED THYROID CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THYROIDECTOMY; TUMOR GROWTH; TUMOR LOCALIZATION;

ADULT; AGE FACTORS; AGED; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863988009     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0899-z     Document Type: Article

References (24)

1. Jarza̧b B, Słowińska-Klencka D (2010) Comment to recommendations: diagnostics and treatment of thyroid cancer. Endokrynol Pol 61:569-574
2. Ward E, Forman D (2011) Global Cancer Statistics. CA Cancer J Clin 61:69-90
3. Wynford TD, Jones CJ, Wyllie FS (1996) The tumour suppressor gene p53 as a regulator of proliferative life-span and tumour progression. Biol Signals 5:139-153
4. Fagin JA (1995) Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancers. J Endocrinol Invest 18:140-142
5. Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155-168
6. Akslen LA, Haldorsen T, Thoresen SO, Glattre E (1991) Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res 51:1234-1241
7. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T (1987) Papillary and follicular thyroid cancer. Prognostic factors in 1, 578 patients. Am J Med 83:479-488
8. DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
9. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo DA et al (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363-369
10. Sciuto R, Romano L, Real S, Marandino F, Sperduti I, Maini CL (2009) Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol 20:1728-1735
11. Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Werber J (1976) Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 184:541-553
12. Shaha AR, Shah JP, Loree TR (1996) Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 3:534-538
13. Bhattacharyya N (2003) A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg 128:115-123
14. So YK, Son YI, Hong SD, Seo MY, Baek CH, Jeong HS et al (2010) Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery 148:526-531
15. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40
16. Cappelli C, Castellano M, Braga M, Gandossi E, Pirola I, De Martino E et al (2007) Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a monoinstitutional experience. J Surg Oncol 95:555-560
17. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713-3720
18. Gulben K, Berberoglu U, Celen O, Mersin HH (2008) Incidental papillary microcarcinoma of the thyroid-factors affecting lymph node metastasis. Langenbecks Arch Surg 393:25-29
19. Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. A comparative analysis. Cancer 103:2269-2273
20. Machens A, Holzhausen HJ, Lautenschläger C, Thanh PN, Dralle H (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. A multivariate analysis of clinical risk factors. Cancer 98:712-719
21. Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375-384
22. Scheumann GF, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559-568
23. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428
24. Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683-689